Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Microglial Ablation and Mesenchymal Stem Cell Transplantation on a Cuprizone-Induced Demyelination Model Publisher Pubmed



Tahmasebi F1 ; Pasbakhsh P2 ; Barati S3 ; Madadi S4 ; Kashani IR2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomy, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Department of Anatomy, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Anatomy, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran

Source: Journal of Cellular Physiology Published:2021


Abstract

Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system with symptoms such as neuroinflammation, astrocytosis, microgliosis, and axonal degeneration. Mesenchymal stem cells (MSCs) with their immunomodulation, differentiation, and neuroprotection abilities can influence the remyelination process. The goal of this study is to investigate the impact of microglial ablation and MSCs transplantation on remyelination processes in the corpus callosum (CC) of the cuprizone demyelination model. For the induction of a chronic demyelination model, C57BL6 mice were fed with chow containing 0.2% cuprizone (wt/wt) for 12 weeks. For the depletion of microglia, PLX3397 was used as a colony-stimulating factor 1 receptor inhibitor for 21 days. MSCs were injected to the right lateral ventricle and after 2 weeks, the mice were killed. We assessed glial cells using specific markers such as APC, Iba-1, and GFAP using the immunohistochemistry method. Remyelination was evaluated by Luxol fast blue (LFB) staining and transmission electron microscope (TEM). The specific genes of microglia and MSCs were evaluated by a quantitative real-time polymerase chain reaction. According to the results of the study, 21 days of PLX3397 treatment significantly reduced microglial cells, and MSCs transplantation decreased the number of astrocytes, whereas the oligodendrocytes population increased significantly in PLX + MSC group in comparison with the cuprizone mice. Furthermore, PLX and MSC treatment elevated levels of remyelination compared with the cuprizone group, as confirmed by LFB staining and TEM analysis. The molecular results showed that MSC transplantation significantly decreased the number of microglia through the CX3CL1/CX3CR1 axis. These results revealed that PLX3397 treatment and MSCs injection reduced microgliosis and astrocytosis. It also increased the oligodendrocytes population by enhancing remyelination in the CC of the cuprizone model of MS. © 2020 Wiley Periodicals LLC
Related Docs
View other Related Docs
1. Effect of the Csf1r Inhibitor Plx3397 on Remyelination of Corpus Callosum in a Cuprizone-Induced Demyelination Mouse Model, Journal of Cellular Biochemistry (2019)
2. Mesenchymal Stem Cell Mediated Effects on Microglial Phenotype in Cuprizone-Induced Demyelination Model, Journal of Cellular Biochemistry (2019)
3. Effect of Mesenchymal Stem Cells on Glial Cells Population in Cuprizone Induced Demyelination Model, Neuropeptides (2019)
4. Effect of Csf1r Inhibitor on Glial Cells Population and Remyelination in the Cuprizone Model, Neuropeptides (2021)
5. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model, Molecular Neurobiology (2022)
6. Protective Features of Calorie Restriction on Cuprizone-Induced Demyelination Via Modulating Microglial Phenotype, Journal of Chemical Neuroanatomy (2021)
7. Astrocyte Ablation Induced by La-Aminoadipate (L-Aaa) Potentiates Remyelination in a Cuprizone Demyelinating Mouse Model, Metabolic Brain Disease (2019)
8. Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination, Neurotoxicity Research (2022)
Experts (# of related papers)
View all Related Experts
Iraj Ragerdi Kashani (12)
Parichehr Pasbakhsh (9)
Other Related Docs
9. 17Β-Estradiol Reduces Demyelination in Cuprizone-Fed Mice by Promoting M2 Microglia Polarity and Regulating Nlrp3 Inflammasome, Neuroscience (2021)
10. Combination Effects of Mesenchymal Stem Cells Transplantation and Anodal Transcranial Direct Current Stimulation on a Cuprizone-Induced Mouse Model of Multiple Sclerosis, Journal of Molecular Histology (2022)
11. Calorie Restriction Promotes Remyelination in a Cuprizone-Induced Demyelination Mouse Model of Multiple Sclerosis, Metabolic Brain Disease (2020)
12. Immunopathogenesis of Multiple Sclerosis: Molecular and Cellular Mechanisms and New Immunotherapeutic Approaches, Immunopharmacology and Immunotoxicology (2024)
13. The Clinical Trials of Mesenchymal Stromal Cells Therapy, Stem Cells International (2021)
14. Therapeutic Potential of Stem Cells for Treatment of Neurodegenerative Diseases, Biotechnology Letters (2020)
15. Metformin Therapy Attenuates Pro-Inflammatory Microglia by Inhibiting Nf-Κb in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis, Neurotoxicity Research (2021)
16. Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction, Cellular and Molecular Neurobiology (2021)